GVN: Forefront Of Virology COVID-19 Webinar Series
Featuring Dr. Donald Ingber – July 27, 2021 – “Human Organ Chip-Enabled Discovery of Antiviral Therapeutics for Influenza, COVID-19, and Beyond”
Donald Ingber, MD, PhD
Wyss Institute for Biologically Inspired Engineering at Harvard University, USA
GVN Center Director
Donald E. Ingber, MD, PhD is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He received his B.A., M.A., M.Phil., M.D. and Ph.D. from Yale University.
Ingber is a pioneer in the field of biologically inspired engineering, and at the Wyss Institute, he currently leads scientific and engineering teams that cross a broad range of disciplines to develop breakthrough bioinspired technologies to advance healthcare and to improve sustainability. His work has led to major advances in mechanobiology, cell structure, tumor angiogenesis, tissue engineering, systems biology, nanobiotechnology and translational medicine, with his most recent pioneering contribution being the development of human Organ-on-Chips as replacements for animal testing and personalized medicine. Through his work, Ingber has helped to break down boundaries between science, art and design, and he also has made great strides in translating his innovations into commercial products with many now either in clinical trials or currently being sold. His Organ Chip technology was named one of the Top 10 Emerging Technologies by the World Economic Forum, Design of the Year by the London Design Museum, and is now included in the Museum of Modern Art (MoMA) in New York’s permanent design collection. He also has authored more than 500 publications and over 165 issued or pending U.S. patents, founded 5 companies, has been a guest speaker at more than 550 events internationally, and was named one of the Top 20 Translational Researchers world-wide in 2012 and 2020. Ingber is a member of the National Academy of Medicine, National Academy of Engineering, National Academy of Inventors, American Institute for Medical and Biological Engineering, and the American Academy of Arts and Sciences.